Mechanochemical tumescentless endovenous ablation: Final results of the initial clinical trial

Phlebology

Volumn 27, Issue 2, 2012, Pages 67-72

  Elias, S ^a   Raines, Jeffrey K ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Chronic venous disease; Endovenous techniques; Ultrasound guided sclerotherapy; Varicose veins; Venous insufficiency

Indexed keywords

SCLEROSING AGENT; TETRADECYL SULFATE SODIUM;

ADVERSE OUTCOME; ANESTHESIA INDUCTION; ARTICLE; CATHETER; CATHETER ABLATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ENDOSCOPIC SCLEROTHERAPY; FOLLOW UP; HUMAN; LOCAL ANESTHESIA; MECHANOTRANSDUCTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SAPHENOUS VEIN; VEIN INSUFFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; CATHETER ABLATION; CHRONIC DISEASE; ENDOVASCULAR PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SAPHENOUS VEIN; SCLEROSING SOLUTIONS; SCLEROTHERAPY; VARICOSE VEINS;

EID: 84856845953     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1258/phleb.2011.010100     Document Type: Article

References (11)

1. Merchant RF, DePalma RG, Kabnick LS. Endovascular obliteration of saphenous reflux: a multicenter study. J Vasc Surg 2002;35:1280-92
2. Cavezzi A, Frullini A, Ricci S, Tessari L. Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology 2002;17:13-8
3. Almeida JI, Kaufman J, Gockeritz O, et al. Radiofrequency endovenous closureFAST versus laser ablation for the treatment of great saphenous reflux: a multicenter single-blinded randomized study (RECOVERY). J Vasc Interv Radiol 2009;20:752-9
4. Proebstle TM, Vago B, Alm J, et al. Treatment of the incompetent great saphenous vein by endovenous radiofrequency powered segmental thermal ablation: first clinical experience. J Vasc Surg 2008;47:151-6
5. Brar R, Nordon IM, Hinchliffe RJ, et al. Surgical management of varicose veins: meta-analysis. Vascular 2010;18: 205-20
6. Blaise S, Bosson JL, Diamond JM. Ultrasound guided sclerotherapy of the great saphenous vein with 1% versus 3% polidocanol foam: a multicentre double-blind randomized trial with three-year follow-up. Eur J Vasc Surg 2010;39:774-8
7. Hamel Desnos C, Ouvry P, Benigni JP, et al. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomized double blind trial with two year follow-up.'The 3/1 study'. Eur J Vasc Surg 2007;34:723-9
8. Ceulen RPM, Bullens-Goessens Y, Pi-Van de V, et al. Outcomes and side effects of duplex guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: Results of a randomized controlled trial with one year follow up. Dermatol Surg 2007;33:276-81
9. Rutherford RB, Padberg FT Jr, Comerota AJ, Kistner RL, Meissner MH, Moneta GL. Venous severity scoring: an adjunct to venous outcome assessment. J Vasc Surg 2000;31:1307-12
10. Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004;40:1248
11. Elias S. Tumescentless endovenous ablation: where are we and where are we going? International Vein Congress (Oral Presentation, May 2010, Miami, FL, USA)